Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

MENRIUM 5-2

CHLORDIAZEPOXIDE; ESTROGENS, ESTERIFIED

Standard Dose
5MG;0.2MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview MENRIUM 5-2 is listed in Drugs@FDA under application 014740 (NDA).

Marketing status: Discontinued Active ingredient CHLORDIAZEPOXIDE; ESTROGENS, ESTERIFIED Form and strength TABLET;ORAL - 5MG;0.2MG Sponsor ROCHE Submission history Latest submission status date: 1996-03-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview MENRIUM 5-2 is listed in Drugs@FDA under application 014740 (NDA). Marketing status: Discontinued Active ingredient CHLORDIAZEPOXIDE; ESTROGENS, ESTERIFIED Form and strength TABLET;ORAL - 5MG;0.2MG Sponsor ROCHE Submission history Latest submission status date: 1996-03-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
MENRIUM 5-2 (CHLORDIAZEPOXIDE; ESTROGENS, ESTERIFIED) | Drug Monograph | MedicHelpline